Recent Publications

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Amaria RN, Menzies AM, Burton EM, Scolyer RA, Tetzlaff MT, Antdbacka R, Ariyan C, Bassett R, Carter B, Daud A, Faries M, Fecher LA, Flaherty KT, Gershenwald JE, Hamid O, Hong A, Kirkwood JM, Lo S, Margolin K, Messina J, Postow MA, Rizos H, Ross MI, Rozeman EA, Saw RPM, Sondak V, Sullivan RJ, Taube JM, Thompson JF, van de Wiel BA, Eggermont AM, Davies MA; International Neoadjuvant Melanoma Consortium members, Ascierto PA, Spillane AJ, van Akkooi ACJ, Wargo JA, Blank CU, Tawbi HA, Long GV.
Lancet Oncol. 2019 Jul;20(7):e378-e389. doi: 10.1016/S1470-2045(19)30332-8. Review.

ASO Author Reflections: The Impacts of a Negative Sentinel Lymph Node on Quality of Life.
Banting S, Gyorki DE.
Ann Surg Oncol. 2019 Jun 21. doi: 10.1245/s10434-019-07523-4. [ Epub ahead of print ] No abstract available.
PMID: 31228135

Negative Sentinel Lymph Node Biopsy in Patients with Melanoma: The Patient’s Perspective.
Banting S, Milne D, Thorpe T, Na L, Spillane J, Speakman D, Henderson MA, Gyorki DE.
Ann Surg Oncol. 2019 Jul;26(7):2263-2267. doi: 10.1245/s10434-019-07375-y. Epub 2019 Apr 22.
PMID: 31011899

Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA.
Tan L, Sandhu S, Lee RJ, Li J, Callahan J, Ftouni S, Dhomen N, Middlehurst P, Wallace A, Raleigh J, Hatzimihalis A, Henderson MA, Shackleton M, Haydon A, Mar V, Gyorki DE, Oudit D, Dawson MA, Hicks RJ, Lorigan P, McArthur GA, Marais R, Wong SQ, Dawson SJ.
Ann Oncol. 2019 May 1;30(5):804-814. doi: 10.1093/annonc/mdz048.
PMID: 30838379

All Publications

For the full list of publications please visit this PubMed page.